Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), is an important and evolving form of insulin delivery, which is mainly used for people with type 1 diabetes.
For example, the precision of insulin infusion rates over the life span of a pump might be acceptable at the time of manufacture but may not be as precise following several years of real-world use.
The market is segmented by product types, including general-purpose infusion pumps, such as large-volume, syringe, electronic ambulatory, and elastomeric pumps, as well as specialty pumps such as ...
The so-called 'hybrid closed-loop' system comprises a blood glucose sensor, the MiniMed 670G insulin pump and an infusion patch. Type 1 diabetes patients using the device will no longer have to ...
is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for ... traditional insulin pumps, pump supplies, and pharmaceuticals.